Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
Intensive Care Med ; 24(8): 821-8, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9757927

ABSTRACT

OBJECTIVE: The aim of this study was to show the feasibility of a slow, continuously increasing level of positive end-expiratory pressure (PEEP) (ramp manoeuvre) in selecting best PEEP and to evaluate whether best PEEP, as defined by maximal oxygen transport, coincides with best systemic arterial oxygenation or best compliance. DESIGN: In 11 anaesthetized piglets, PEEP was increased between 0 cmH2O (zero end-expiratory pressure; ZEEP) and 15 cmH2O (PEEP15) with a constant rate of 0.67 cmH2O x min(-1). This ramp manoeuvre was performed both under normal conditions and after induction of an experimental lung oedema. During the ramp manoeuvre, haemodynamic and pulmonary variables were monitored almost continuously. RESULTS: During the rise in PEEP, cardiac output declined in a non-linear way. In the series with normal conditions, best PEEP was always found at ZEEP. In the series with experimental lung oedema, best PEEP, as defined by maximum oxygen transport, was found at PEEP1-6, as defined by maximal compliance, at PEEP7.5 and by maximal arterial oxygen tension (PaO2) at PEEP10-14. CONCLUSIONS: Best PEEP according to oxygen transport is lower than best PEEP according to compliance and PaO2; the use of PEEP as a ramp might prevent unnecessarily high levels of PEEP.


Subject(s)
Positive-Pressure Respiration/methods , Pulmonary Edema/therapy , Animals , Blood Gas Analysis , Disease Models, Animal , Feasibility Studies , Hemodynamics , Monitoring, Physiologic/methods , Point-of-Care Systems/standards , Positive-Pressure Respiration/standards , Pulmonary Edema/blood , Regression Analysis , Swine
3.
Circulation ; 92(10): 2848-54, 1995 Nov 15.
Article in English | MEDLINE | ID: mdl-7586251

ABSTRACT

BACKGROUND: Myoglobin and fatty acid-binding protein (FABP) each are useful as early biochemical markers of muscle injury. We studied whether the ratio of myoglobin over FABP in plasma can be used to distinguish myocardial from skeletal muscle injury. METHODS AND RESULTS: Myoglobin and FABP were assayed immunochemically in tissue samples of human heart and skeletal muscle and in serial plasma samples from 22 patients with acute myocardial infarction (AMI), from 9 patients undergoing aortic surgery (causing injury of skeletal muscles), and from 10 patients undergoing cardiac surgery. In human heart tissue, the myoglobin/FABP ratio was 4.5 and in skeletal muscles varied from 21 to 73. After AMI, the plasma concentrations of both proteins were elevated between approximately 1 and 15 to 20 hours after the onset of symptoms. In this period, the myoglobin/FABP ratio was constant both in subgroups of patients receiving and those not receiving thrombolytics and amounted to 5.3 +/- 1.2 (SD). In serum from aortic surgery patients, both proteins were elevated between 6 and 24 hours after surgery; the myoglobin/FABP ratio was 45 +/- 22 (SD), which is significantly different from plasma values in AMI patients (P < .001). In patients with cardiac surgery, the ratio increased from 11.3 +/- 4.7 to 32.1 +/- 13.6 (SD) during 24 hours after surgery, indicating more rapid release of protein from injured myocardium than from skeletal muscles. CONCLUSIONS: The ratio of the concentrations of myoglobin over FABP in plasma from patients with muscle injury reflects the ratio found in the affected tissue. Since this ratio is different between heart (4.5) and skeletal muscle (20 to 70), its assessment in plasma allows the discrimination between myocardial and skeletal muscle injury in humans.


Subject(s)
Carrier Proteins/blood , Fatty Acids/metabolism , Muscle, Skeletal/injuries , Myelin P2 Protein/blood , Myocardial Infarction/diagnosis , Myoglobin/blood , Neoplasm Proteins , Tumor Suppressor Proteins , Aged , Aorta, Abdominal/surgery , Carrier Proteins/analysis , Case-Control Studies , Coronary Artery Bypass , Enzyme-Linked Immunosorbent Assay , Fatty Acid-Binding Protein 7 , Fatty Acid-Binding Proteins , Female , Fibrinolytic Agents/therapeutic use , Heart Valve Prosthesis , Humans , Male , Middle Aged , Muscle, Skeletal/chemistry , Myelin P2 Protein/analysis , Myocardial Infarction/blood , Myocardial Infarction/drug therapy , Myocardium/chemistry , Myoglobin/analysis , Streptokinase/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...